| Natural product-derived phytochemicals as potential agents against coronaviruses: A review JS Mani, JB Johnson, JC Steel, DA Broszczak, PM Neilsen, KB Walsh, ... Virus research 284, 197989, 2020 | 471 | 2020 |
| The oncogenic role of miR-155 in breast cancer S Mattiske, RJ Suetani, PM Neilsen, DF Callen Cancer epidemiology, biomarkers & prevention 21 (8), 1236-1243, 2012 | 334 | 2012 |
| Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion PAJ Muller, AG Trinidad, P Timpson, JP Morton, S Zanivan, ... Oncogene 32 (10), 1252-1265, 2013 | 217 | 2013 |
| Mutant p53 drives invasion in breast tumors through up-regulation of miR-155 PM Neilsen, JE Noll, S Mattiske, CP Bracken, PA Gregory, RB Schulz, ... Oncogene 32 (24), 2992-3000, 2013 | 181 | 2013 |
| Ankrd11 is a chromatin regulator involved in autism that is essential for neural development D Gallagher, A Voronova, MA Zander, GI Cancino, A Bramall, MP Krause, ... Developmental cell 32 (1), 31-42, 2015 | 156 | 2015 |
| Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells NT Pfister, V Fomin, K Regunath, JY Zhou, W Zhou, L Silwal-Pandit, ... Genes & development 29 (12), 1298-1315, 2015 | 148 | 2015 |
| Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome PM Neilsen, JE Noll, RJ Suetani, RB Schulz, F Al-Ejeh, A Evdokiou, ... Oncotarget 2 (12), 1203, 2011 | 120 | 2011 |
| Identification of ANKRD11 as a p53 coactivator PM Neilsen, KM Cheney, CW Li, JD Chen, JE Cawrse, RB Schulz, ... Journal of cell science 121 (21), 3541-3552, 2008 | 101 | 2008 |
| FBXO31 is the chromosome 16q24. 3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex R Kumar, PM Neilsen, J Crawford, R McKirdy, J Lee, JA Powell, Z Saif, ... Cancer research 65 (24), 11304-11313, 2005 | 95 | 2005 |
| Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9 JLY Chee, S Saidin, DP Lane, SM Leong, JE Noll, PM Neilsen, YT Phua, ... Cell Cycle 12 (2), 278-288, 2013 | 86 | 2013 |
| Nutlin-3a is a potential therapeutic for ewing sarcoma KI Pishas, F Al-Ejeh, I Zinonos, R Kumar, A Evdokiou, MP Brown, ... Clinical Cancer Research 17 (3), 494-504, 2011 | 83 | 2011 |
| Mutant p53 drives multinucleation and invasion through a process that is suppressed by ANKRD11 JE Noll, J Jeffery, F Al-Ejeh, R Kumar, KK Khanna, DF Callen, PM Neilsen Oncogene 31 (23), 2836-2848, 2012 | 78 | 2012 |
| Inhibition of DNA-dependent protein kinase induces accelerated senescence in irradiated human cancer cells A Azad, S Jackson, C Cullinane, A Natoli, PM Neilsen, DF Callen, ... Molecular Cancer Research 9 (12), 1696-1707, 2011 | 72 | 2011 |
| Characterization of ANKRD11 mutations in humans and mice related to KBG syndrome K Walz, D Cohen, PM Neilsen, J Foster, F Brancati, K Demir, R Fisher, ... Human genetics 134, 181-190, 2015 | 62 | 2015 |
| p53 represses the oncogenic Sno-MiR-28 derived from a SnoRNA F Yu, CP Bracken, KA Pillman, DM Lawrence, GJ Goodall, DF Callen, ... PloS one 10 (6), e0129190, 2015 | 61 | 2015 |
| Antioxidative and therapeutic potential of selected Australian plants: A review JS Mani, JB Johnson, H Hosking, N Ashwath, KB Walsh, PM Neilsen, ... Journal of Ethnopharmacology 268, 113580, 2021 | 56 | 2021 |
| CBFA2T3-ZNF652 corepressor complex regulates transcription of the E-box gene HEB R Kumar, KM Cheney, R McKirdy, PM Neilsen, RB Schulz, J Lee, J Cohen, ... Journal of biological chemistry 283 (27), 19026-19038, 2008 | 46 | 2008 |
| Targeting the p53 pathway in Ewing sarcoma PM Neilsen, KI Pishas, DF Callen, DM Thomas Sarcoma 2011, 2010 | 45 | 2010 |
| Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer R Shakya, GA Tarulli, L Sheng, NA Lokman, C Ricciardelli, KI Pishas, ... Oncogene 36 (31), 4469-4480, 2017 | 41 | 2017 |
| Systematic characterisation of the rat and human CYP24A1 promoter R Kumar, DN Iachini, PM Neilsen, J Kaplan, J Michalakas, PH Anderson, ... Molecular and cellular endocrinology 325 (1-2), 46-53, 2010 | 33 | 2010 |
